Background
Wearable smartphone-enabled cardiac monitoring devices can aid the diagnosis of asymptomatic tachycardia in neonates and infants and do not require a medical prescription. The Owlet ® 'smart sock' (Owlet Baby Care, Liss, Hampshire, UK) uses pulse oximetry technology to track the heart rate and oxygen levels of infants and sends information on these measurements to the smartphone of the mother and father via its application (App) when the heart rate or oxygen levels vary from pre-set values. This 'smart sock' is currently not approved by the US Food and Drug Administration (FDA) as a diagnostic medical device. This report is of a rare case of left posterior fascicular ventricular tachycardia of Belhassen type detected in a neonate by 'smart sock' cardiac monitoring.
Case Report
A baby boy was born prematurely at 37 weeks gestational age (birth weight, 3,170 gm) by Cesarean section due to breech presentation and premature rupture of membranes. He was discharged home after three days without complication and was followed up daily in the office of his pediatrician for the management of hyperbilirubinemia, which was treated using a phototherapy blanket. His father had bought Owlet ® smart socks (Owlet Baby Care, Liss, Hampshire, UK) which were used at home ( Figure 1) He was admitted to the emergency room (ER) at 6 days of age because his 'smart socks' identified a tachycardia of between 180-200 bpm. His parents reported no fever, cough, nasal congestion, or emesis. On examination in the ER, he was alert with no distress. His temperature was 97.8°F (36.6°C), pulse rate 198 bpm, respiration rate 42/min, blood pressure 69/42 mmHg, and his pulse oximetry was 100%. An electrocardiogram (ECG) showed a sustained monomorphic and wide QRS (0.11 sec) tachycardia with a heart rate of 200 bpm, right bundle branch block (RBBB), and a superior axis without a discernible P-wave ( Figure 2A ), which was compatible with a diagnosis of left posterior fascicular ventricular tachycardia (VT) of Belhassen type. The echocardiogram showed a structurally normal heart with a patent foramen ovale normal cardiac function.
He was breastfed and was latching on frequently, which indicated possible dehydration. Laboratory investigations showed a glucose level of 47 mg/dL, and a repeat glucose level of 36 mg/dL. He was given a bolus of intravenous dextrose 10% in water (D10W), which resulted in an improvement of the glucose value to 140 mg/dL. His total bilirubin was 16.8 mg/dL, his blood urea nitrogen (BUN) was 9 mg/dL, his serum creatinine was 0.28 mg/dL, and his sodium was slightly elevated at 148 mmol/L. His tachycardia spontaneously converted to normal sinus rhythm after four hours ( Figure 2B ). He was started on propranolol 2 mg/kg/day (tid). Telemetry monitoring showed that he was in sinus rhythm with a heart rate that ranged between 7-130 bpm without any cardiac arrhythmia. Because there was a concern that his mother's breast milk was not sufficient and resulted in his hypoglycemia and hyperbilirubinemia, he was given formula milk as a supplement during his hospital stay, with 45 mL every three hours of a combination of breast milk and infant formula. The glucose and bilirubin levels returned to normal, and he was discharged home three days later. Propranolol was discontinued when he was one month of age. Cardiac monitoring using 'smart socks' continued at home, and no further arrhythmias were detected at one year of age.
Discussion
This report demonstrated the diagnostic role of the 'smart sock' wearable smartphone-enabled cardiac monitoring device in a newborn baby and identified an unusually high heart rate at six days old. Admission to hospital following tachycardia that was identified by the parents at home resulted in the diagnosis of the rare condition of left posterior fascicular ventricular tachycardia (VT) of Belhassen type before the neonate developed any cardiac symptom. 
